Mona M. Riskalla

Mona M. Riskalla

Pediatric Rheumatology

303 East Nicollet Boulevard
Suite 372
Burnsville, MN 55337

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.

Journal: Immunotherapy

Published: June 18, 2025

Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.

Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.

Journal: ACR open rheumatology

Published: June 05, 2025

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study.

Journal: Blood advances

Published: July 23, 2024

Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.

Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors.

Journal: Clinical and experimental rheumatology

Published: April 10, 2024

Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.

Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 03, 2024

Histocompatibility Leukocyte Antigen-A29-Associated Retinal Vasculitis without Choroidal Lesions: A Report of 4 Cases.

Histocompatibility Leukocyte Antigen-A29-Associated Retinal Vasculitis without Choroidal Lesions: A Report of 4 Cases.

Journal: Journal of clinical medicine

Published: October 07, 2023

Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.

Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease.

Journal: Arthritis care & research

Published: April 19, 2023

HLA-DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis.

HLA-DRB1*15 and Eosinophilia Are Common Among Patients With Systemic Juvenile Idiopathic Arthritis.

Journal: Arthritis care & research

Published: December 09, 2022

Capturing critical data elements in Juvenile Idiopathic Arthritis: initiatives to improve data capture.

Capturing critical data elements in Juvenile Idiopathic Arthritis: initiatives to improve data capture.

Journal: Pediatric rheumatology online journal

Published: May 19, 2022

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series.

Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series.

Journal: Pediatric rheumatology online journal

Published: May 13, 2022

Using quality improvement methodology and tools to reduce patient wait time in a paediatric subspecialty rheumatology clinic.

Using quality improvement methodology and tools to reduce patient wait time in a paediatric subspecialty rheumatology clinic.

Journal: BMJ open quality

Published: May 21, 2021

Emergent high fatality lung disease in systemic juvenile arthritis.

Emergent high fatality lung disease in systemic juvenile arthritis.

Journal: Annals of the rheumatic diseases

Published: July 17, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026